Organizing Committee
OCM Member
Professor, Microbiology and Immunology
National Research Center in Egypt , Egypt
Biography :

Dr. Ahmed G. Hegazi is working as a professor of Microbiology & Immunology at National Research Center, Dept. Zoonotic Diseases from 2004.He also has work experience as prestigious chair in Dept.of Parasitology and Animal Diseases,National Research Center. He received many awards like Senior Scientist Prize of National Research Center(1996),National Scientific Prize In Biological Sciences(1990),The Second Best Research Paper award From International Congress of propolis, Bones Aires, Argentina(2000) and many more. He Conducted training courses on Clinical Microbiology, National Research Center in 1979. He has 225 articles in national and international scientific journals along with four patents.

Research Interest :

Microbiology and Immunology

OCM Member
Apllied pharmacologist, european specialist lab. medicine EC4 REGISTERED
University of Pavia , Italy
Biography :

Editorial membership ? Highlights clinical and cellular immunology heighpubs from 2018 ? Review of public administration and management omics from 4/2017 ? Journal of Pharmaceutics & Pharmacology aven 2016 ? GLS journal of clinical pathology 2017 ? Global scientific library ? Advances in Neurology and Neuroscience ? International Journal of Economics and Management Science March 2016 ? American journal of pharmacology and pharmacotherapeutics since 2016 ? Journal of Bioanalysis & Biomedicine ISSN: 1948-593X 2016 ? Modern approaches in drug design ? Journal of Infectious Diseases and Medical Microbiology ( allied acc. ) ? Journal of Pharmaceutical Chemistry and Pharmacology ? Journal of Biomedical and Pharmaceutical Sciences ? Statistical editor role from 8/9/2016 for 1 year in Universal journal of pharmaceutical research www.ujpr.org ? Intern medicine open access (from 9/2017) ? Open access journal of addiction and psychology IRIS pub ? Open access journal of toxicology juniper ( 2017 since Nov. 2018) Conferences –congress role • International advisory committee: at ICFPSR – 2017 Columbia Institute of pharmacy 2nd International Conference " Frontier in Pharmaceutical Sciences and Research" RABIPUR INDIA ? Innovate dementia 2017 board membership Brisbane Australia ? 5th International Conference on Clinical Pharmacy and Healthcare IT March 30-31, 2018 Orlando, Florida, USA o Board member ? TOXICOLOGY 2018 ROME POSTER PRESENTATION World Summit on Toxicology ROME 2018 brain response in some systemic immune condition- toxicological aspects SCIENTIFIC FEDERATION ? Regional antidotes annual congress 2018 BOLOGNA ITALY RER 11-6-2018 8 speaker role. ? MANY OTHER INVITE TO BE BOARD OF INTERNATIONAL CONGRESS IN MANY DISCIPLINE AS TOXICOLOGY, PHARMACOLOGY, NEUROSCIENCE ET OTHER ? World summit on toxicology Rome 2018 organizing committee membership SCIENTIFIC FEDERATION ? OFFICIALLY INVITED TO Euro Global Congress on Toxicology & Applied Pharmacology https://tychonixinternational.org/toxicology-europe ? OFFICIALLY INVITED TO World Congress of Regenerative Medicine & Stem Cell scheduled from December 7-9, 2018 CHINA

Research Interest :

Clinical pharmacology, pharmacoeconomy, new professional social media , biomedical database , EBM

OCM Member
Professor Emerita , Applied Research Institute in Jerusalem
Southern Illinois University Edwardsville , USA
Biography :

Dr. DeGarmo is a Professor Emerita at Southern Illinois University Edwardsville, USA and research associate for the Applied Research Institute in Jerusalem. Her expertise consists of international security with a focus on the nuclear era and security in the Middle East. She has also been a facilitator for the Foreign Policy's Great Decisions program at the university since 2001. Dr. DeGarmo previously spent several years as a department chair of the political science department at Southern Illinois University Edwardsville. A recipient of numerous research grants over the years, she has also received numerous awards for her contributions, including a Meridian Award for 2011 and 2012, and a Dr. Martin Luther King Jr. Humanitarian Award in 2011, all granted by Southern Illinois University Edwardsville. She has also been named as the recipient of the “Lifetime Achievement Award” and “Who’s Who of Professional Women” by Marquis in 2017. She also served on the Organizing Committee and as Keynote Speaker for “Environmental Toxicology and Ecological Risk Assessment”September 24-25, 2018 Chicago, Illinois, USA. Professor DeGarmo has authored four books, "The Geneva Conventions of 1949 and Their Protocols: The Case of Israel" in 2016, “The U.S.-Israeli Strategic Alliance and the Disappearing Palestine” in 2016, “The Disposal of Radioactive Wastes in the Metropolitan St. Louis Area: The Environmental and Health Legacy of the Mallinckrodt Chemical Works” in 2006, and “International Environmental Treaties and State Behavior: Factors Influencing Cooperation,” in 2004. She has also written a number of book chapters, contributions to both encyclopedias and professional journals, and undergraduate teaching manuals. Beyond those literary accomplishments, Dr. Degarmo has conducted over two dozen book and article reviews, and has served as a presenter and chair for many conference proceedings since 1994.

Research Interest :

Clinical pharmacology, pharmacoeconomy, new professional social media , biomedical database , EBM

OCM Member
CEO/Toxicologist
SteelFusion Clinical Toxicology Laboratories , USA
Biography :

Amy J. Reisinger, Chief Executive Officer and Toxicologist, SteelFusion Clinical Toxicology Laboratory, LLC - Ms. Reisinger studied Biology/Pre-Medicine at The University of North Carolina in Wilmington, North Carolina and completed postgraduate studies for the Cardiovascular Perfusion Program at Duquesne University in Pittsburgh, Pennsylvania. Ms. Reisinger began her professional career as an Extra Corporeal Membrane Oxygenator (ECMO) Specialist and Histologist at Children’s Hospital of Pittsburgh, Pennsylvania, where she monitored patient’s hemodynamics following critical physician orders, and administered medications. Additionally, she supported the pathology and toxicology departments by conducting toxicology interpretations and assisting in the collection of pathological specimens during autopsy procedures. She became a Research Scientist at GlaxoSmithKline, Research Triangle Park, North Carolina, where she provided regulatory support to the pharmaceutical industry. Ms. Reisinger was responsible for performing the gross and microscopic examinations of animals utilized in toxicology studies as well as evaluating the significance of the anatomic and clinical pathology, as well as organ weight data from such studies. Additional responsibilities included: generating pathology interpretations to accurately reflect the data and provide significance for drug registration and drug safety; review study protocols and contribute to the design of pathologic evaluations; train necropsy technicians to conduct Good Laboratory Practice (GLP) compliant work utilizing Standard Operating Procedures (SOPs); and keeping abreast of current scientific literature in toxicological pathology. Ms. Reisinger is a Registered Histotechnician and Registered Histologist with the American Society of Clinical Pathologists. Based on her knowledge of toxicology and pathology and understanding the logistics of performing clinical studies in accordance with GLPs, Ms. Reisinger served as a Study Director/Monitor at Bristol-Myers Squibb Company in Mt. Vernon, Indiana for GLP and non-GLP toxicology studies, including investigative and mechanistic studies. She prepared schedules for study activities; conducted data reviews; evaluated scientific data to develop conclusions derived from the studies undertaken; prepared reports and summaries of toxicology studies; prepared safety/risk assessments for human health based on preclinical study results; ensured compliance with GLPs and SOPs, Quality Assurance, safety and animal welfare guidelines, and other state and federal regulations. Ms. Reisinger maintained knowledge of worldwide testing and registration requirements and initiated and monitored Contract Research Organization (CRO) studies. Additionally, Ms. Reisinger presented at scientific meetings and published papers in journals; participated in the investigation of complex toxicity findings encountered in nonclinical toxicity studies; maintained an excellence in knowledge and evaluation group through their application in drug discovery and development; critically evaluated Human and Veterinary Pharmaceuticals; prepared Safety Data Sheets (SDSs) and prepared Chemical Hygiene Plans (CHPs) for the safe handling of chemicals including test articles and formulation components. SteelFusion Clinical Toxicology Laboratory, LLC, was established in 2014 by Ms. Reisinger as a women-owned and operated toxicology laboratory specializing in clinical and forensic toxicology services. Amy has been serving as the President and CEO of the laboratory since its inception. She is a member of Women’s Business Enterprise National Council, Society of Toxicology, American College of Toxicology, International Association of Coroners and Medical Examiners, American Society Clinical Pathology, Project Management Institute, and National Society of Histotechnology. From 2016 through 2018, Ms. Reisinger was awarded three US Patents for the rapid and sensitive method of forensic toxicology in Post-mortem subjects using oral fluid testing. She has extensive experience and expertise working with WBENC, CLIA, CAP, DOH, OSHA, SHARP, ISO, ABFT, ANAB and other regulations and guidelines governing the use of chemicals and drugs in the marketplace. Ms. Reisinger performed Graduate Studies in Perfusion Technology, Duquesne University, Pittsburgh, PA, 1993 BS, Biology, University of North Carolina, Wilmington, Wilmington, NC, 1991. She is a Registered Histotechnician and Histotechnologist and is published in Neuropharm, Toxicologic Pathology, and Journal of the American Association Laboratory Animal Science. Ms. Reisinger is also a member of the Society of Toxicology, American College of Toxicology, American Association of Laboratory Animal Science, American Society for Clinical Pathology, National Society for Histotechnology, and Project Management Institute.

Research Interest :

Clinical pharmacology, pharmacoeconomy, new professional social media , biomedical database , EBM

Allied Academies Global Conference Directory

Copyright © 2020-2021 Allied Academies, All Rights Reserved.